Skip to content

Subarachnoid or Infiltration for Hemorrhoidectomy

Comparative Study of the Analgesic Effect of Subarachnoid or Infiltration for Hemorrhoidectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01927874
Enrollment
40
Registered
2013-08-23
Start date
2013-01-31
Completion date
2015-11-30
Last updated
2016-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhoid

Keywords

infiltration, hemorrhoidectomy, Postoperative pain

Brief summary

There will be compared the postoperative analgesic effect of infiltration or spinal block for hemorrhoidectomy

Detailed description

This is a prospective, randomized study, including 40 patients between 18 and 60 years, of both genders, ASA 1 or 2. Patients in group 1 (n = 20) will be submitted to spinal block and group 2 (n = 20) to infiltration. The spinal block will be performed with 10 mg of 0.5% bupivacaine. The infiltration will be performed with 10 ml of 0.5% bupivacaine with epinephrine on each side. Will be evaluated: intensity of pain on a numerical scale from 0 to 10 every 15 minutes, relaxation of the sphincter muscles, intensity of pain after the operation every 30 minutes until reached the criteria for discharge, muscle strength of the lower limbs every 30 minutes, BP, HR, SO2, FR, other items that determine the conditions of discharge (urine output, nausea and vomiting), time to hospital discharge, and duration of analgesia. Adverse effects and complications will be noted.

Interventions

PROCEDUREInfiltration

injection of local anesthetic, associated with general anesthesia

PROCEDURESpinal block

injection of anesthetic

DRUGBupivacaine

10ml 0.5% bupivacaine.

DRUG10 mg of hyperbaric 0.5% bupivacaine

Spinal punction and injection of local anesthetic

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Will be included 50 patients, ASA physical status 1 or 2 undergoing hemorrhoidectomy after approval by the Ethics Committee and signed Consent Form

Exclusion criteria

* There will be excluded patients with associated diseases (fistula, fissure), infection at the puncture site, using anticoagulants or analgesics (up to 2 weeks before the procedure) and pregnant.

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity24 hoursNumerical score

Secondary

MeasureTime frame
Time to discharge24 hours

Other

MeasureTime frame
Duration of motor blockade24 hours

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026